BLPH

Bellerophon Therapeutics, Inc.

Delisted

BLPH was delisted on the 13th of October, 2023.

15 hedge funds and large institutions have $8.35M invested in Bellerophon Therapeutics, Inc. in 2016 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 5 increasing their positions, 1 reducing their positions, and 4 closing their positions.

Holders
15
Holders Change
-1
Holders Change %
-6.25%
% of All Funds
0.38%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
3
Increased
5
Reduced
1
Closed
4
Calls
Puts
Net Calls
Net Calls Change
Name Market Value Shares Shares
Change
Shares
Change %
NMVA
1
New Mountain Vantage Advisers
New York
$5.5M 10,574,171 +5,714,286 +118%
BC
2
Boxer Capital
California
$966K 1,857,143 +1,857,143 New
Fidelity Investments
3
Fidelity Investments
Massachusetts
$633K 1,208,070
AC
4
Armistice Capital
New York
$520K 1,000,000 +1,000,000 New
SM
5
Sabby Management
Florida
$414K 789,857 +789,857 New
Renaissance Technologies
6
Renaissance Technologies
New York
$124K 239,100 +183,600 +331%
Alyeska Investment Group
7
Alyeska Investment Group
Illinois
$80K 154,290 +1,230 +0.8%
LPL Financial
8
LPL Financial
California
$51K 95,035 +24,000 +34%
Vanguard Group
9
Vanguard Group
Pennsylvania
$28K 53,719
Citadel Advisors
10
Citadel Advisors
Florida
$15K 28,120 +10,942 +64%
Creative Planning
11
Creative Planning
Kansas
$10K 19,098
GA
12
Geneva Advisors
Illinois
$7K 12,500
VKH
13
Virtu KCG Holdings
New York
$6K 11,590 -20,788 -64%
UBS Group
14
UBS Group
Switzerland
-9,267 Closed
Envestnet Asset Management
15
Envestnet Asset Management
Illinois
-1,000 Closed
TRCT
16
Tower Research Capital (TRC)
New York
-700 Closed
Bank of America
17
Bank of America
North Carolina
-1 Closed
Royal Bank of Canada
18
Royal Bank of Canada
Ontario, Canada
$0 181
Morgan Stanley
19
Morgan Stanley
New York
$0 500